Literature DB >> 22760103

Central nervous system aquaporin-4 autoimmunity presenting with an isolated cerebral abnormality.

Su-Hyun Kim1, Woojun Kim, Myeong-Cherl Kook, Eun-kyung Hong, Ho Jin Kim.   

Abstract

Advances in the understanding of central nervous system aquarporin-4 autoimmunity have promoted the recognition of diverse clinical presentations beyond the traditional view of neuromyelitis optica. We describe a patient who developed hemiparesis caused by an extensive cerebral lesion as an initial manifestation of central nervous system aquarporin-4 autoimmunity. Although the patient had no history of optic neuritis or myelitis, not only was serum anti-aquarporin-4 antibody positive, but an imaging, treatment response and histopathological features also revealed characteristic findings suggestive of central nervous system aquarporin-4 autoimmunity. The present case highlights the importance of a comprehensive evaluation for anti-aquarporin-4 antibody even in patients presenting with isolated cerebral lesions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22760103     DOI: 10.1177/1352458512441271

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  7 in total

1.  Central nervous system Aquaporin4 autoimmunity revealed by a single pseudotumoral encephalic lesion.

Authors:  Guillaume Fargeot; J Aboab; J Savatovsky; R Marignier; A Lecler; O Gout
Journal:  Metab Brain Dis       Date:  2017-10-31       Impact factor: 3.584

2.  A longitudinal brain magnetic resonance imaging study of neuromyelitis optica spectrum disorder.

Authors:  Su-Hyun Kim; So-Young Huh; Jae-Won Hyun; In Hye Jeong; Sang Hyun Lee; AeRan Joung; Ho Jin Kim
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

3.  Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis.

Authors:  Masataka Nakamura; Kumi Itani; Kousuke Miyake; Takenobu Kunieda; Satoshi Kaneko; Hirofumi Kusaka
Journal:  Intern Med       Date:  2017-01-15       Impact factor: 1.271

4.  Different Phenotypes at Onset in Neuromyelitis Optica Spectrum Disorder Patients with Aquaporin-4 Autoimmunity.

Authors:  Youming Long; Junyan Liang; Linzhan Wu; Shaopeng Lin; Cong Gao; Xiaohui Chen; Wei Qiu; Yu Yang; Xueping Zheng; Ning Yang; Min Gao; Yaotang Chen; Zhanhang Wang; Quanxi Su
Journal:  Front Neurol       Date:  2017-02-28       Impact factor: 4.003

5.  Magnetic resonance imaging brain findings in a case of aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder, presenting with intractable vomiting and hiccups.

Authors:  Prerna Garg; Muthusubramanian Rajasekaran; Salil Pandey; Gnanashanmugam Gurusamy; Devanand Balalakshmoji; Rajakumar Rathinasamy
Journal:  J Neurosci Rural Pract       Date:  2017 Jan-Mar

Review 6.  Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases.

Authors:  Aigli G Vakrakou; Maria-Evgenia Brinia; Ioanna Svolaki; Theodore Argyrakos; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Front Neurol       Date:  2022-03-15       Impact factor: 4.003

7.  Brain abnormalities in neuromyelitis optica spectrum disorder.

Authors:  Woojun Kim; Su-Hyun Kim; So-Young Huh; Ho Jin Kim
Journal:  Mult Scler Int       Date:  2012-12-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.